Formula (Gabapentin Fig1)
Gabapentin Capsule
Product Images NDC 71205-373
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71205-373). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Gabapentin Fig2)
The data seems to be a graph displaying the mean pain score for different treatment periods using a placebo or the drug Gabapentin at a dosage of 3600 mg/day. The study had a baseline and lasted for 7 weeks. However, further information is not available due to the limited amount of text.*
Figure 2 (Gabapentin Fig3)
The text describes a table with different treatment periods and doses for managing pain. The table contains columns for mean pain score and baseline measurements. It includes three different treatment options; Placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. However, there is not enough information in the text to determine the type or cause of pain being studied.*
Figure 3 (Gabapentin Fig4)
The text describes a graph named "Figure 3" that shows the proportion of responders in controlled PHN studies. The graph presents different percentages, including 100%, 70%, 50%, and 30%. Additionally, the graph shows the results of two studies labeled "Study 1" and "Study 2." Unfortunately, there is some corrupted text, and it is not possible to extract the full meaning from it.*
Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Gabapentin Fig5)
71205-373-15 (Gabapentin Fig9)
This is a description of Gabapentin 100mg capsules distributed by ProficientRx with the NDC 71205-373-15. The capsules are white and have "D" imprinted on the white cap and "02" on the white body. The capsules are filled with white to off-white crystalline powder. Each capsule contains 100mg of Gabapentin USP. The medication guide provided separately must be given to each patient. The medication should be stored at 20°-25°C (68°-77°F) and kept out of the reach of children. The product is packaged by Proficient Rx LP in Thousand Oaks, CA, and manufactured by Aurobindo Pharma USA, Inc. in India. The lot number of the product is 00000 and the expiration date is not available. The product ID is QG037315 and the GTIN is 00371205373153.*
Chemical Structure (Gabapentin Str)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
